Nutex Health (NUTX) Stock Price

Nutex Health Price

NASDAQ·CLOSED
151.93USD-5.78 (-3.73 %)
Market closed

Over the last 11 years Nutex Health grew revenue by 69.3% annually, reaching 479.95 M USD. For Nutex Health, the net margin of 10.9% is up versus -356.2% a few years ago. The consensus 12-month price target for Nutex Health is 234.60 USD, about 54.4% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus. The stock trades about 88% above its 52-week low.

Nutex Health stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Nutex Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Nutex Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Nutex Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Nutex Health Stock Price History
DateNutex Health Price
8/6/2026151.93 USD
8/5/2026157.71 USD
8/4/2026157.14 USD
8/3/2026152.93 USD
7/31/2026147.43 USD
7/30/2026148.71 USD
7/29/2026142.01 USD
7/27/2026150.57 USD
7/23/2026153.56 USD
7/22/2026157.21 USD
7/21/2026168.27 USD
7/20/2026161.47 USD
7/17/2026162.98 USD
7/16/2026164.40 USD
7/15/2026176.00 USD
7/14/2026178.37 USD
7/13/2026178.67 USD
7/10/2026183.91 USD
7/9/2026183.36 USD
7/8/2026185.07 USD
7/7/2026187.90 USD
7/6/2026198.04 USD
7/2/2026196.53 USD
7/1/2026190.71 USD
6/30/2026170.89 USD
6/29/2026168.38 USD
6/26/2026166.40 USD
6/25/2026149.10 USD
6/24/2026147.54 USD
6/23/2026147.23 USD
6/22/2026143.51 USD
6/18/2026149.22 USD
6/17/2026146.66 USD
6/16/2026144.60 USD
6/15/2026147.49 USD
6/12/2026148.12 USD
6/11/2026138.70 USD
6/10/2026135.00 USD
6/9/2026135.40 USD
6/8/2026134.41 USD
6/5/2026132.80 USD
6/4/2026134.15 USD
6/3/2026125.76 USD
6/2/2026127.52 USD
6/1/2026126.70 USD
5/29/2026133.15 USD
5/28/2026134.97 USD
5/27/2026121.91 USD
5/26/2026125.90 USD
5/22/2026118.02 USD
5/21/2026116.22 USD
5/20/2026120.50 USD
5/19/2026126.39 USD
5/18/2026124.70 USD
5/15/2026126.30 USD
5/14/2026127.84 USD
5/13/2026131.90 USD
5/12/2026135.48 USD
5/11/2026132.88 USD
5/8/2026136.66 USD
5/7/2026134.59 USD
5/6/2026130.59 USD
5/5/2026121.00 USD
5/4/2026147.17 USD
5/1/2026139.57 USD
4/30/2026119.20 USD
4/29/2026112.02 USD
4/28/2026115.09 USD
4/27/2026110.79 USD
4/24/2026108.24 USD
4/23/2026108.86 USD
4/22/2026108.39 USD
4/21/2026106.18 USD
4/20/2026109.28 USD
4/17/2026105.58 USD
4/16/2026101.76 USD
4/15/2026109.00 USD
4/14/2026107.84 USD
4/13/2026106.27 USD
4/10/2026101.05 USD
4/9/2026105.70 USD
4/8/2026105.04 USD
4/7/2026102.90 USD
4/6/2026100.65 USD
4/2/2026100.92 USD
4/1/202698.44 USD
3/31/202695.04 USD
3/30/202690.90 USD
3/27/202693.81 USD
3/26/202694.86 USD
3/25/2026100.38 USD
3/24/202699.49 USD
3/23/202694.98 USD
3/20/202688.99 USD
3/19/202694.66 USD
3/18/202694.06 USD
3/17/202694.01 USD
3/16/202692.70 USD
3/13/202688.80 USD
3/12/202687.01 USD
3/11/202690.49 USD
3/10/202696.78 USD
3/9/202698.61 USD
3/6/202690.28 USD
3/5/2026105.34 USD
3/4/2026108.44 USD
3/3/2026111.90 USD
3/2/2026117.60 USD
2/27/2026110.46 USD
2/26/2026115.77 USD
2/25/2026108.47 USD
2/24/202699.19 USD
2/23/2026101.75 USD
2/20/2026101.08 USD
2/19/2026103.61 USD
2/18/2026104.51 USD
2/17/2026101.33 USD
2/13/202699.71 USD
2/12/2026105.02 USD
2/11/2026103.00 USD
2/10/2026101.38 USD
2/9/2026104.64 USD
2/6/202699.90 USD
2/5/2026101.97 USD
2/4/2026125.10 USD
2/3/2026154.47 USD
2/2/2026161.25 USD
1/30/2026148.79 USD
1/29/2026148.53 USD
1/28/2026149.80 USD
1/27/2026153.81 USD
1/26/2026159.74 USD
1/23/2026156.21 USD
1/22/2026159.42 USD
1/21/2026146.97 USD
1/20/2026153.76 USD
1/16/2026152.77 USD
1/15/2026164.21 USD
1/14/2026165.90 USD
1/13/2026172.60 USD
1/12/2026180.72 USD
1/9/2026186.18 USD
1/8/2026184.11 USD
1/7/2026178.09 USD
1/6/2026171.95 USD
1/5/2026167.64 USD
1/2/2026148.19 USD
12/31/2025164.62 USD
12/30/2025182.23 USD
12/29/2025183.88 USD
12/26/2025176.68 USD
12/24/2025168.10 USD
12/23/2025167.34 USD
12/22/2025179.55 USD
12/19/2025171.93 USD
12/18/2025166.84 USD
12/17/2025159.00 USD
12/16/2025171.72 USD
12/15/2025175.78 USD
12/12/2025184.89 USD
12/11/2025190.49 USD
12/10/2025176.47 USD
12/9/2025168.42 USD
12/8/2025181.06 USD
12/5/2025160.95 USD
12/4/2025156.79 USD
12/3/2025131.75 USD
12/2/2025129.77 USD
12/1/2025119.58 USD
11/28/2025115.11 USD
11/26/2025112.80 USD
11/25/2025119.21 USD
11/24/2025137.21 USD
11/21/2025136.92 USD
11/20/2025142.34 USD
11/19/2025112.19 USD
11/18/202599.20 USD
11/17/2025103.95 USD
11/14/2025107.11 USD
11/13/2025108.81 USD
11/12/2025121.65 USD
11/11/2025111.97 USD
11/10/2025118.86 USD
11/7/2025114.65 USD
11/6/2025121.74 USD
11/5/2025131.32 USD
11/4/2025126.71 USD
11/3/2025131.71 USD
10/31/2025123.06 USD
10/30/2025124.50 USD
10/29/2025127.83 USD
10/28/2025128.68 USD
10/27/2025129.48 USD
10/24/2025125.57 USD
10/23/2025117.30 USD
10/22/2025114.31 USD
10/21/2025114.50 USD
10/20/2025111.00 USD
10/17/202594.83 USD
10/16/202596.70 USD
10/15/2025106.01 USD
10/14/202599.47 USD
10/13/2025102.16 USD
10/10/202594.83 USD
10/9/2025103.68 USD
10/8/2025102.74 USD
10/7/2025102.76 USD
10/6/2025108.62 USD
10/3/2025107.88 USD
10/2/2025107.19 USD
10/1/2025104.40 USD
9/30/2025103.32 USD
9/29/2025106.23 USD
9/26/2025102.53 USD
9/25/202597.07 USD
9/24/2025100.31 USD
9/23/2025103.68 USD
9/22/202599.71 USD
9/19/202596.11 USD
9/18/202592.96 USD
9/17/202589.98 USD
9/16/202588.08 USD
9/15/202595.66 USD
9/12/202597.19 USD
9/11/202592.00 USD
9/10/202583.24 USD
9/9/202585.90 USD
9/8/202583.41 USD
9/5/202583.38 USD
9/4/202585.88 USD
9/3/202582.05 USD
9/2/202580.92 USD
8/29/202583.79 USD
8/28/202588.39 USD
8/27/202589.78 USD
8/26/202590.05 USD
8/25/202589.51 USD
8/22/202592.40 USD
8/21/202596.18 USD
8/20/202592.75 USD
8/19/202594.96 USD
8/18/202594.55 USD
8/15/202592.91 USD
8/14/2025111.13 USD
8/13/2025105.19 USD
8/12/202596.12 USD
8/11/202589.63 USD
Access this data via the Eulerpool API
Get Free API Key

Nutex Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
1.59 M USD
-3.52 M USD
-5.65 M USD
Jan 1, 2021
18.79 M USD
-9.02 M USD
-13.67 M USD
Jan 1, 2022
219.29 M USD
-4.58 M USD
-424.78 M USD
Jan 1, 2023
247.65 M USD
-1.29 M USD
-45.79 M USD
Jan 1, 2024
479.95 M USD
137.71 M USD
52.18 M USD
Jan 1, 2025 (e)
982.40 M USD
-4.86 M USD
99.47 M USD
Jan 1, 2026 (e)
880.37 M USD
-4.35 M USD
152.15 M USD
Jan 1, 2027 (e)
969.21 M USD
-4.79 M USD
162.82 M USD

Nutex Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 9, 2026, 9:09 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2013201420152016201720182019202020212022202320242025e2026e2027e
1.001.00––––1.001.0018.00219.00247.00479.00982.00880.00969.00
––––––––1,700.001,116.6712.7993.93105.01-10.3910.11
19,600.0019,600.00––––19,600.0019,600.0022.225.9413.7740.9240.9240.9240.92
196.00196.00196.00196.00196.00196.00196.00196.004.0013.0034.00196.00401.82360.08396.50
––––-2.00-1.00-4.00-3.00-9.00-4.00-1.00137.00-4.00-4.00-4.00
––––––-400.00-300.00-50.00-1.83-0.4028.60-0.41-0.45-0.41
–––-7.00–-2.00-7.00-5.00-13.00-424.00-45.0052.0099.00152.00162.00
––––––250.00-28.57160.003,161.54-89.39-215.5690.3853.546.58
5.375.375.37–––0.020.030.254.234.415.375.375.375.37
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Nutex Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Nutex Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Nutex Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Nutex Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Nutex Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Nutex Health stock margins

The Nutex Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nutex Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nutex Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
42.62 %
-222.01 %
-356.24 %
Jan 1, 2021
22.07 %
-47.98 %
-72.74 %
Jan 1, 2022
6.13 %
-2.09 %
-193.70 %
Jan 1, 2023
14.04 %
-0.52 %
-18.49 %
Jan 1, 2024
40.89 %
28.69 %
10.87 %
Jan 1, 2025 (e)
40.89 %
-0.49 %
10.13 %
Jan 1, 2026 (e)
40.89 %
-0.49 %
17.28 %
Jan 1, 2027 (e)
40.89 %
-0.49 %
16.80 %

Nutex Health Stock Revenue, EBIT, Earnings per Share

The Nutex Health earnings per share therefore indicates how much revenue Nutex Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
48.06 USD
-106.70 USD
-171.21 USD
Jan 1, 2021
75.48 USD
-36.22 USD
-54.90 USD
Jan 1, 2022
51.81 USD
-1.08 USD
-100.35 USD
Jan 1, 2023
56.18 USD
-0.29 USD
-10.39 USD
Jan 1, 2024
89.33 USD
25.63 USD
9.71 USD
Jan 1, 2025 (e)
138.95 USD
-0.90 USD
14.07 USD
Jan 1, 2026 (e)
124.52 USD
-0.81 USD
21.52 USD
Jan 1, 2027 (e)
137.09 USD
-0.89 USD
23.03 USD

Nutex Health business model & stock analysis

Nutex Health Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Nutex Health Employees
Details
Date
Nutex Health Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Nutex Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Nutex Health historical P/E ratio, EBIT multiple, and P/S ratio

Nutex Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Nutex Health shares outstanding

The number of shares of Nutex Health was 5.37 M in 2025. This indicates how many shares Nutex Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
33,000.00 Stocks
Jan 1, 2021
249,000.00 Stocks
Jan 1, 2022
4.23 M Stocks
Jan 1, 2023
4.41 M Stocks
Jan 1, 2024
5.37 M Stocks
Jan 1, 2025 (e)
5.37 M Stocks
Jan 1, 2026 (e)
5.37 M Stocks
Jan 1, 2027 (e)
5.37 M Stocks

Nutex Health stock splits

In Nutex Health's history, there have been no stock splits.

Current Nutex Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
88.89 % (8)
Hold
11.11 % (1)
Sell
0.00 % (0)
12M Price Target
234.60
Last Price
162.07
Currency
USD
12M Return Potential
44.75 %
LTM Return
0 %

Nutex Health Analyst Rating Actions

DateFirmActionRatingReliability
8/26/2025
Maxim Group
Maxim Group
MaintainedBuy–
7/10/2025
Benchmark
Benchmark
MaintainedBuy71
5/20/2025
Maxim Group
Maxim Group
MaintainedBuy–
5/15/2025
Benchmark
Benchmark
MaintainedBuy71
4/9/2025
Benchmark
Benchmark
MaintainedBuy71
4/8/2025
Maxim Group
Maxim Group
MaintainedBuy–
2/13/2025
Maxim Group
Maxim Group
MaintainedBuy–
11/12/2024
Maxim Group
Maxim Group
MaintainedBuy–
11/12/2024
Benchmark
Benchmark
MaintainedBuy71
8/21/2024
Benchmark
Benchmark
MaintainedBuy71

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Nutex Health Earnings Calls

Nutex Health Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/12/20265.05USD-219.33 MUSD-2026 Q2
5/11/20264.98USD-232.45 MUSD-2026 Q1
11/7/2024-0.78USD-70.79 MUSD-2024 Q3
5/13/2024-USD-74.05 MUSD-2024 Q1
2/29/2024-0.01USD-68.20 MUSD-2023 Q4

EESG©

Eulerpool ESG Scorecard© for the Nutex Health stock

41/100
43
Environment
28
Social
51
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Nutex Health shareholder structure

% Name
7.87223%
Topline Capital Management, LLC
Topline Capital Management, LLC
3.19031%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
2.68638%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.47190%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
1.33731%
Marshall Wace LLP
Marshall Wace LLP
1.11540%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
...

Nutex Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
49.4%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
41.59%
Thomas T. Vo
Thomas T. Vo
SEC ↗
41.59%
Micro Hospital Holding LLC
Micro Hospital Holding LLC
SEC ↗
16.49%
DOMINISEMBREE AHA INVESTOR, LLC
DOMINISEMBREE AHA INVESTOR, LLC
SEC ↗
12.00%
2
2
SEC ↗
9.90%
Topline Capital Management, LLC
Topline Capital Management, LLC
SEC ↗
6.55%
Premier Macy Management Holdings, LLC
Premier Macy Management Holdings, LLC
SEC ↗
6.55%
Matthew Stephen Young
Matthew Stephen Young
SEC ↗
6.55%
Cynthia J. Young
Cynthia J. Young
SEC ↗
5.90%
Pertento Partners LLP
Pertento Partners LLP
SEC ↗
5.30%
BlackRock, Inc.
BlackRock, Inc.
SEC ↗

Nutex Health Executives and Management Board

12 members · avg. age 61 · 33 % women

WH

Dr. Warren Hosseinion (53)

President, Director · since 2019

1.24 M USD

Management

TV

Dr. Thomas Vo (52)

Chairman of the Board, Chief Executive Officer · since 2022

1.16 M USD
JB

Mr. Jon Bates (55)

Chief Financial Officer

682,578.00 USD
EL

Ms. Elisa Luqman (61)

Chief Legal Officer · since 2019

593,322.00 USD
PM

Ms. Pamela Montgomery (68)

Chief Legal Officer - Healthcare, Corporate Secretary

275,355.00 USD
MC

Mr. Michael Chang (54)

Chief Medical Officer

–
JR

Ms. Jennifer Rodriguez

Investor Relations · since 2023

–

Board of Directors

MC

Mr. Mitchell Creem (69)

Independent Director

169,160.00 USD
MR

Mr. Michael Reed (67)

Lead Independent Director

165,000.00 USD
CG

Ms. Cheryl Grenas (65)

Independent Director

162,500.00 USD
SS

Mr. Scott Saunders (62)

Independent Director

107,955.00 USD
KS

Dr. Kelvin Spears (64)

Director

–

Frequently asked questions about Nutex Health

Analysts currently set an average price target of 255.00 USD for the Nutex Health stock (median: 234.60 USD), implying +57.3 % versus the latest price. The consensus is based on 9 analyst ratings.

Nutex Health Analyst Price Targets 2026

9 analysts currently rate the Nutex Health stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Nutex Health to generate revenue of 880.37 M USD and earnings per share of 28.32 USD.

Nutex Health Analyst Price Targets 2026

Converted at the current exchange rate, the Nutex Health share trades at 131.56 EUR (151.93 USD).

The Nutex Health share (NUTX) is listed on 1 stock exchanges, including: NASDAQ (NUTX).

No history available for Nutex Health.

The expected revenue of Nutex Health is 880.37 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Nutex Health is 152.15 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nutex Health is currently 5.37. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nutex Health stock.

The price-to-sales ratio (P/S) of Nutex Health is currently 0.93. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nutex Health stock.

The Eulerpool Quality Score for Nutex Health is 7/10.

The ISIN of Nutex Health is US67079U3068. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Nutex Health is NUTX. The ticker symbol is used to trade Nutex Health shares on the stock exchange.

Nutex Health paid dividends every year for the past 0 years.

Nutex Health is assigned to the 'Health' sector.

The dividends of Nutex Health are distributed in USD.

All fundamentals and in-depth analysis of Nutex Health

Our stock analysis for Nutex Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nutex Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Nutex Health Stock
Nutex Health Revenue→
Nutex Health Stock
Nutex Health Net Income→
Nutex Health Stock
Nutex Health P/E→
Nutex Health Stock
Nutex Health P/S→
Nutex Health Stock
Nutex Health EBIT→
Nutex Health Stock
Nutex Health Dividend→
Nutex Health Stock
Nutex Health Directors Dealings→
Nutex Health Stock
Nutex Health Stocks→
Nutex Health Stock
Nutex Health Market capitalization→
Nutex Health Stock
Nutex Health Debt→
Nutex Health Stock
Nutex Health Liabilities→
Nutex Health Stock
Nutex Health Equity→
Nutex Health Stock
Nutex Health AAQS→
Nutex Health Stock
Nutex Health Employees→
Nutex Health Stock
Nutex Health ROE→
Nutex Health Stock
Nutex Health ROA→
Nutex Health Stock
Nutex Health ROCE→
Nutex Health Stock
Nutex Health News→
Nutex Health Stock
Nutex Health Analyst Price Targets→

Health Stocks

Nutra PharmaNutex Befektetesi NyrtNuvalentNurix TherapeuticsNuvation BioNurecaNuvectis PharmaNuformixNuwellisNuCanaNxera Pharma CoNRX PharmaceuticalsAll Stocks A–Z →